StockMacro
Menu

Zura Bio

$0.93 -78% in 6 monthsMarket cap $89.6M

ZURA on XNAS, Health Care, Zura Bio Limited, job postings

Measures activity, not value. Not investment advice.

Shares fell 77% in one month while cash of $187.7M sits against an $89.6M market cap.

  • BadShort interest 8.8% of shares, up 21% from two weeks earlier
  • GoodInstitutional holders rose 26%, from 95 the quarter before to 120

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
40
Website
zurabio.com
Listed
Nasdaq, US
Last results
27 Oct 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $25.8M.
Quarter to 31 Dec 2021: revenue –, net income $818KQuarter to 31 Mar 2022: revenue –, net income $148KQuarter to 30 Jun 2022: revenue –, net income $2.3MQuarter to 30 Sep 2022: revenue –, net income $458KQuarter to 31 Dec 2022: revenue –, net income $672KQuarter to 31 Mar 2023: revenue –, net income -$9.6MQuarter to 30 Jun 2023: revenue –, net income -$34.0MQuarter to 30 Sep 2023: revenue –, net income -$8.3MQuarter to 31 Mar 2024: revenue –, net income -$7.7MQuarter to 30 Jun 2024: revenue –, net income -$10.3MQuarter to 30 Sep 2024: revenue –, net income -$20.7MQuarter to 31 Dec 2024: revenue –, net income -$13.6MQuarter to 31 Mar 2025: revenue –, net income -$17.4MQuarter to 30 Jun 2025: revenue –, net income -$16.0MQuarter to 30 Sep 2025: revenue –, net income -$18.0MQuarter to 31 Dec 2025: revenue –, net income -$17.2MQuarter to 31 Mar 2026: revenue –, net income -$24.2MQuarter to 30 Jun 2026: revenue –, net income -$26.3MQuarter to 30 Sep 2026: revenue –, net income -$25.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $34.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$25.8M
30 Jun 2026–-$26.3M
31 Mar 2026–-$24.2M
31 Dec 2025–-$17.2M
30 Sep 2025–-$18.0M
30 Jun 2025–-$16.0M
31 Mar 2025–-$17.4M
31 Dec 2024–-$13.6M
30 Sep 2024–-$20.7M
30 Jun 2024–-$10.3M
31 Mar 2024–-$7.7M
30 Sep 2023–-$8.3M
30 Jun 2023–-$34.0M
31 Mar 2023–-$9.6M
31 Dec 2022–$672K
30 Sep 2022–$458K
30 Jun 2022–$2.3M
31 Mar 2022–$148K
31 Dec 2021–$818K
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$93.5M -$65.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.12 -$0.65
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -65.4% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$53.5M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $187.7M $139.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$187.7M (net cash) -$139.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.84
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.50 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Zura BioZURA (this company) $89.6Mloss–––
LENZ TherapeuticsLENZ $93.2Mloss7.5––
Outlook TherapeuticsOTLK $94.9Mloss–––
Voyager TherapeuticsVYGR $95.2Mloss3.8-21%-416%
Black Diamond TherapeuticsBDTX $75.3Mloss–––
Fate TherapeuticsFATE $111.8Mloss23.5-33%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+26%

120 13F filers vs 95

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

72%

69.2M shares held by 13F filers (30 Sep 2026) of 96.3M outstanding (27 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

8.8%

8.5M shares sold short (30 Oct 2026) of 96.3M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.8

8.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+21%

7.0M shares sold short in the report before, 8.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

31%

31% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 41%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

10

10 articles in the last 7 days; its usual week has 1.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.7×

10 articles in the last 7 days; its usual week has 1.5.

Price $0.93 on 20 Nov 2026, -75% over 12 months (12-month range $0.93 to $7.04)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $12.5M in the last 12 months (the 12 months before: $0).
Capital spending per quarter. Capital spending $13K in the latest quarter, -73% on a year earlier.
Institutional holders (13F filers). 120 13F filers reported holding it in the latest 13F quarter, +90% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
18 Jun 20268-K and other filingsDirector or officer change
22 May 20268-K and other filingsDirector or officer change
28 Apr 2026Sharp changeShort interest spike: short interest spike, 6.2M vs usual 2.6M (2026-04-15); 2.4x the same period a year earlier
23 Apr 20268-K and other filingsDirector or officer change
14 Apr 2026Sharp changeShort interest spike: short interest spike, 5.8M vs usual 2.6M (2026-03-31); 1.1x the same period a year earlier
23 Feb 20268-K and other filingsDirector or officer change
23 Jan 20268-K and other filingsDirector or officer change
2 Jan 20268-K and other filingsA major agreement ended
17 Dec 20258-K and other filingsDirector or officer change
10 Oct 20258-K and other filingsDirector or officer change
30 Sep 20258-K and other filingsDirector or officer change
30 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Jul 20258-K and other filingsDirector or officer change
1 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Feb 2025Sharp changeShort interest spike: short interest spike, 4.9M vs usual 786K (2025-01-31); 14.9x the same period a year earlier
28 Jan 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 716K (2025-01-15); 14.1x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 687K (2024-12-31); 11.3x the same period a year earlier
31 Dec 2024Sharp changeShort interest spike: short interest spike, 5.0M vs usual 653K (2024-12-13); 23.2x the same period a year earlier
17 Dec 2024Sharp changeShort interest spike: short interest spike, 5.2M vs usual 636K (2024-11-29); 29.8x the same period a year earlier
3 Dec 2024Sharp changeShort interest spike: short interest spike, 5.0M vs usual 599K (2024-11-15); 28.9x the same period a year earlier
19 Nov 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 516K (2024-10-31); 3.8x the same period a year earlier
29 Oct 2024Sharp changeShort interest spike: short interest spike, 1.9M vs usual 449K (2024-10-15); 7.0x the same period a year earlier
18 Oct 20248-K and other filingsDirector or officer change
15 Oct 2024Sharp changeShort interest spike: short interest spike, 1.9M vs usual 433K (2024-09-30); 6.5x the same period a year earlier
27 Aug 2024Sharp changeShort interest spike: short interest spike, 4.0M vs usual 371K (2024-08-15); 23.5x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 3.4M vs usual 356K (2024-07-31); 18.6x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 341K (2024-07-15); 11.0x the same period a year earlier
25 Jul 20248-K and other filingsDirector or officer change
25 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 May 20248-K and other filingsRegistered new securities for sale (S-1)
6 May 20248-K and other filingsPrivate placement of securities (Form D)
25 Apr 2024Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 4.2M)
28 Mar 20248-K and other filingsDirector or officer change
23 Feb 20248-K and other filingsChanged its auditor
8 Jan 20248-K and other filingsDirector or officer change
6 Dec 20238-K and other filingsDirector or officer change
3 Oct 20238-K and other filingsDirector or officer change
3 Oct 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Sep 20238-K and other filingsRegistered new securities for sale (S-1)
25 Aug 20238-K and other filingsRegistered new securities for sale (S-1)
11 Aug 20238-K and other filingsRegistered new securities for sale (S-1)
21 Jul 20238-K and other filingsRegistered new securities for sale (S-1)
14 Jun 20238-K and other filingsRegistered new securities for sale (S-1)
5 May 20238-K and other filingsPrivate placement of securities (Form D)
10 Apr 20238-K and other filingsDirector or officer change
7 Apr 20238-K and other filingsDirector or officer change
24 Mar 20238-K and other filingsDirector or officer change
24 Mar 20238-K and other filingsCompleted an acquisition or asset sale
24 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Apr 20228-K and other filingsEarlier financial statements can no longer be relied on
31 Mar 20228-K and other filingsReport will be filed late
Insider net buying (open market)
Month from 1 Jun 2023: $500K published
Month from 1 Dec 2023: -$8.0M published
Month from 1 Apr 2024: $4.2M published
Month from 1 May 2024: $496K published
Month from 1 Sep 2024: -$10.5M published
Month from 1 Nov 2024: -$2.7M published
Month from 1 Mar 2026: $12.5M published
Capital spending per quarter
Quarter ended 31 Mar 2024: $7K; public on 10 May 2024
Quarter ended 30 Jun 2024: $10K; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $13K; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $45K; public on 26 Mar 2025
Quarter ended 31 Mar 2025: $49K, +600% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $15K, +50% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $32K, +146% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $17K, -62% on a year earlier; public on 20 Mar 2026
Quarter ended 31 Mar 2026: $13K, -73% on a year earlier; public on 8 May 2026
Institutional holders (13F filers)
31 Mar 2023 report: 17; public on 15 May 2023
30 Jun 2023 report: 36; public on 14 Aug 2023
30 Sep 2023 report: 40; public on 14 Nov 2023
31 Dec 2023 report: 43; public on 14 Feb 2024
31 Mar 2024 report: 43; public on 15 May 2024
30 Jun 2024 report: 55; public on 14 Aug 2024
30 Sep 2024 report: 75; public on 14 Nov 2024
31 Dec 2024 report: 86; public on 14 Feb 2025
31 Mar 2025 report: 71; public on 15 May 2025
30 Jun 2025 report: 62; public on 14 Aug 2025
30 Sep 2025 report: 63; public on 14 Nov 2025
31 Dec 2025 report: 71; public on 17 Feb 2026
31 Mar 2026 report: 91; public on 15 May 2026
30 Jun 2026 report: 95; public on 14 Aug 2026
30 Sep 2026 report: 120; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $12.5M (2 Mar 2026), higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $12.5M in the last 12 months (the 12 months before: $0).
  • Capital spending per quarter: Capital spending $13K in the latest quarter, -73% on a year earlier.
  • Institutional holders (13F filers): 120 13F filers reported holding it in the latest 13F quarter, +90% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 11 insider trades

No trades in the last 90 days; the latest was filed 2 Mar 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
2 Mar 2026Access Industries Holdings LLC and 3 others10% ownerBuy2,000,000$6.25$12.5MForm 4
27 Nov 2024Parvinder ThiaraDirectorSell1,001,633$2.73$2.7MForm 4
13 Sep 2024Parvinder ThiaraDirectorSell3,800,000$2.70$10.3MForm 4
6 Sep 2024Someit SidhuDirectorSell51,728$3.87$200KForm 4
23 May 2024van Amstel Arnout PloosDirectorBuy80,000$6.20$496KForm 4
24 Apr 2024Kiran NistalaExecutive Vice PresidentBuy3,195$3.13$10KForm 4
24 Apr 2024Someit SidhuDirectorBuy1,186,901$3.13$3.7MForm 4
24 Apr 2024Michael HowellSee RemarksBuy7,987$3.13$25KForm 4

120 institutions reported shares at the end of Q3 2026, 72% of the shares outstanding; 32 opened a position, 7 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Montanova Capital, LLC9.4M9.80%$39.3MNo change
Venrock Adviser, LLC6.4M6.68%$26.8MNo change
MPM Bioimpact LLC4.4M4.62%$18.5M-23K-0.5%
Great Point Partners LLC4.1M4.23%$17.0M-139K-3.3%
Siren, L.L.C.3.7M3.88%$15.5MNo change
BlackRock, Inc.3.7M3.84%$15.4M+85K+2.4%
Commodore Capital LP3.2M3.37%$13.5MNo change
Braidwell LP2.7M2.75%$11.0M-1.3M-33%
Adage Capital Partners GP, L.L.C.2.2M2.34%$9.4M-500K-18%
Saturn V Capital Management LP2.0M2.11%$8.5M-69K-3.3%

Company events

All 51 company events

In 12 months: 6 director or officer changes, 2 major agreements, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
22 May 2026Director or officer change8-K
23 Apr 2026Director or officer change8-K
25 Feb 2026Signed a major agreement8-K
23 Feb 2026Director or officer change8-K
23 Jan 2026Director or officer change8-K
2 Jan 2026Signed a major agreement; A major agreement endedSame filing: sold shares privately8-K
17 Dec 2025Director or officer change8-K

The 5 newest of 97 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 18 Jun 2026Filings record

    Director or officer change

  2. 22 May 2026Filings record

    Director or officer change

  3. 25 Apr 2026Short interest and volume change

    had 6.2M shares sold short in the 15 Apr 2026 report, 2.4× the same report last year.

    Same report last year: 2.6M; its normal report is 2.6M.

    See the evidence
    This period
    6.2M (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    512K
    How far from its usual level
    +4.7
    Same report last year
    2.6M
    History used
    1,111 days
    2025-04-15: 2.6M2025-04-30: 2.5M2025-05-15: 2.5M2025-05-30: 3.1M2025-06-13: 2.7M2025-06-30: 1.2M2025-07-15: 586K2025-07-31: 534K2025-08-15: 545K2025-08-29: 425K2025-09-15: 458K2025-09-30: 2.1M2025-10-15: 2.6M2025-10-31: 2.7M2025-11-14: 2.6M2025-11-28: 2.5M2025-12-15: 2.6M2025-12-31: 2.8M2026-01-15: 3.0M2026-01-30: 3.8M2026-02-13: 4.1M2026-02-27: 4.7M2026-03-13: 5.1M2026-03-31: 5.8M2026-04-15: 6.2M
    the 15 Apr 2026 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 23 Apr 2026Filings record

    Director or officer change

  5. 11 Apr 2026Short interest and volume change

    had 5.8M shares sold short in the 31 Mar 2026 report, 1.1× the same report last year.

    Same report last year: 5.4M; its normal report is 2.6M.

    See the evidence
    This period
    5.8M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    512K
    How far from its usual level
    +4.2
    Same report last year
    5.4M
    History used
    1,096 days
    2025-03-31: 5.4M2025-04-15: 2.6M2025-04-30: 2.5M2025-05-15: 2.5M2025-05-30: 3.1M2025-06-13: 2.7M2025-06-30: 1.2M2025-07-15: 586K2025-07-31: 534K2025-08-15: 545K2025-08-29: 425K2025-09-15: 458K2025-09-30: 2.1M2025-10-15: 2.6M2025-10-31: 2.7M2025-11-14: 2.6M2025-11-28: 2.5M2025-12-15: 2.6M2025-12-31: 2.8M2026-01-15: 3.0M2026-01-30: 3.8M2026-02-13: 4.1M2026-02-27: 4.7M2026-03-13: 5.1M2026-03-31: 5.8M
    the 31 Mar 2026 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 3 Mar 2026Insiders record

    Access Industries Holdings LLC (ten percent owner) and 3 other(s) bought 2,000,000 shares of ZURA ($12.5M) (dated 2 Mar 2026)

  7. 23 Feb 2026Filings record

    Director or officer change

  8. 23 Jan 2026Filings record

    Director or officer change

  9. 2 Jan 2026Filings record

    A major agreement ended

  10. 17 Dec 2025Filings record

    Director or officer change

  11. 10 Oct 2025Filings record

    Director or officer change

  12. 30 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 30 Sep 2025Filings record

    Director or officer change

  14. 1 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 1 Jul 2025Filings record

    Director or officer change

  16. 12 Feb 2025Short interest and volume change

    had 4.9M shares sold short in the 31 Jan 2025 report, 15× the same report last year.

    Same report last year: 329K; its normal report is 786K.

    See the evidence
    This period
    4.9M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    786K
    Typical spread (median absolute deviation)
    456K
    How far from its usual level
    +6.1
    Same report last year
    329K
    History used
    672 days
    2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M2024-11-29: 5.2M2024-12-13: 5.0M2024-12-31: 5.0M2025-01-15: 5.0M2025-01-31: 4.9M
    the 31 Jan 2025 report24 earlier reportsnormal: 786K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 28 Jan 2025Short interest and volume change

    had 5.0M shares sold short in the 15 Jan 2025 report, 14× the same report last year.

    Same report last year: 353K; its normal report is 716K.

    See the evidence
    This period
    5.0M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    716K
    Typical spread (median absolute deviation)
    374K
    How far from its usual level
    +7.7
    Same report last year
    353K
    History used
    656 days
    2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M2024-11-29: 5.2M2024-12-13: 5.0M2024-12-31: 5.0M2025-01-15: 5.0M
    the 15 Jan 2025 report24 earlier reportsnormal: 716K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 14 Jan 2025Short interest and volume change

    had 5.0M shares sold short in the 31 Dec 2024 report, 11× the same report last year.

    Same report last year: 437K; its normal report is 687K.

    See the evidence
    This period
    5.0M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    687K
    Typical spread (median absolute deviation)
    331K
    How far from its usual level
    +8.7
    Same report last year
    437K
    History used
    641 days
    2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M2024-11-29: 5.2M2024-12-13: 5.0M2024-12-31: 5.0M
    the 31 Dec 2024 report24 earlier reportsnormal: 687K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 25 Dec 2024Short interest and volume change

    had 5.0M shares sold short in the 13 Dec 2024 report, 23× the same report last year.

    Same report last year: 216K; its normal report is 653K.

    See the evidence
    This period
    5.0M (the 13 Dec 2024 report)
    Normal report (median of 24 earlier)
    653K
    Typical spread (median absolute deviation)
    298K
    How far from its usual level
    +9.9
    Same report last year
    216K
    History used
    623 days
    2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M2024-11-29: 5.2M2024-12-13: 5.0M
    the 13 Dec 2024 report24 earlier reportsnormal: 653K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 11 Dec 2024Short interest and volume change

    had 5.2M shares sold short in the 29 Nov 2024 report, 30× the same report last year.

    Same report last year: 173K; its normal report is 636K.

    See the evidence
    This period
    5.2M (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    636K
    Typical spread (median absolute deviation)
    280K
    How far from its usual level
    +10.9
    Same report last year
    173K
    History used
    609 days
    2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M2024-11-29: 5.2M
    the 29 Nov 2024 report24 earlier reportsnormal: 636K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 27 Nov 2024Short interest and volume change

    had 5.0M shares sold short in the 15 Nov 2024 report, 29× the same report last year.

    Same report last year: 171K; its normal report is 599K.

    See the evidence
    This period
    5.0M (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    599K
    Typical spread (median absolute deviation)
    248K
    How far from its usual level
    +11.8
    Same report last year
    171K
    History used
    595 days
    2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M2024-11-15: 5.0M
    the 15 Nov 2024 report24 earlier reportsnormal: 599K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 13 Nov 2024Short interest and volume change

    had 1.8M shares sold short in the 31 Oct 2024 report, 3.8× the same report last year.

    Same report last year: 462K; its normal report is 516K.

    See the evidence
    This period
    1.8M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    516K
    Typical spread (median absolute deviation)
    187K
    How far from its usual level
    +4.5
    Same report last year
    462K
    History used
    580 days
    2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M2024-10-31: 1.8M
    the 31 Oct 2024 report24 earlier reportsnormal: 516K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 25 Oct 2024Short interest and volume change

    had 1.9M shares sold short in the 15 Oct 2024 report, 7.0× the same report last year.

    Same report last year: 270K; its normal report is 449K.

    See the evidence
    This period
    1.9M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    449K
    Typical spread (median absolute deviation)
    187K
    How far from its usual level
    +5.2
    Same report last year
    270K
    History used
    564 days
    2023-10-13: 270K2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M2024-10-15: 1.9M
    the 15 Oct 2024 report24 earlier reportsnormal: 449K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 18 Oct 2024Filings record

    Director or officer change

  25. 10 Oct 2024Short interest and volume change

    had 1.9M shares sold short in the 30 Sep 2024 report, 6.5× the same report last year.

    Same report last year: 285K; its normal report is 433K.

    See the evidence
    This period
    1.9M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    433K
    Typical spread (median absolute deviation)
    179K
    How far from its usual level
    +5.4
    Same report last year
    285K
    History used
    549 days
    2023-09-29: 285K2023-10-13: 270K2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M2024-08-30: 663K2024-09-13: 850K2024-09-30: 1.9M
    the 30 Sep 2024 report24 earlier reportsnormal: 433K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 27 Aug 2024Short interest and volume change

    had 4.0M shares sold short in the 15 Aug 2024 report, 24× the same report last year.

    Same report last year: 171K; its normal report is 371K.

    See the evidence
    This period
    4.0M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    371K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +18.4
    Same report last year
    171K
    History used
    503 days
    2023-08-15: 171K2023-08-31: 158K2023-09-15: 257K2023-09-29: 285K2023-10-13: 270K2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M2024-08-15: 4.0M
    the 15 Aug 2024 report24 earlier reportsnormal: 371K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 10 Aug 2024Short interest and volume change

    had 3.4M shares sold short in the 31 Jul 2024 report, 19× the same report last year.

    Same report last year: 185K; its normal report is 356K.

    See the evidence
    This period
    3.4M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    356K
    Typical spread (median absolute deviation)
    123K
    How far from its usual level
    +16.9
    Same report last year
    185K
    History used
    488 days
    2023-07-31: 185K2023-08-15: 171K2023-08-31: 158K2023-09-15: 257K2023-09-29: 285K2023-10-13: 270K2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M2024-07-31: 3.4M
    the 31 Jul 2024 report24 earlier reportsnormal: 356K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 25 Jul 2024Short interest and volume change

    had 1.8M shares sold short in the 15 Jul 2024 report, 11× the same report last year.

    Same report last year: 163K; its normal report is 341K.

    See the evidence
    This period
    1.8M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    341K
    Typical spread (median absolute deviation)
    123K
    How far from its usual level
    +7.9
    Same report last year
    163K
    History used
    472 days
    2023-07-14: 163K2023-07-31: 185K2023-08-15: 171K2023-08-31: 158K2023-09-15: 257K2023-09-29: 285K2023-10-13: 270K2023-10-31: 462K2023-11-15: 171K2023-11-30: 173K2023-12-15: 216K2023-12-29: 437K2024-01-12: 353K2024-01-31: 329K2024-02-15: 383K2024-02-29: 358K2024-03-15: 330K2024-03-28: 628K2024-04-15: 428K2024-04-30: 401K2024-05-15: 721K2024-05-31: 570K2024-06-14: 643K2024-06-28: 710K2024-07-15: 1.8M
    the 15 Jul 2024 report24 earlier reportsnormal: 341K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 25 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 25 Jul 2024Filings record

    Director or officer change

  31. 24 May 2024Filings record

    Registered new securities for sale (S-1)

  32. 24 May 2024Insiders record

    Ploos van Amstel Arnout (director) bought 80,000 shares of ZURA ($496,000) (dated 23 May 2024)

  33. 6 May 2024Filings record

    Private placement of securities (Form D)

  34. 25 Apr 2024Insiders change

    had 4 insiders buy $4.2M of its shares on the open market within 30 days (4 filings).

    Who bought: Munshi Amit, Howell Michael, Sidhu Someit, Nistala Kiran.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $4.2M
    Window
    26 Mar 2024 to 25 Apr 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  35. 25 Apr 2024Insiders record

    Nistala Kiran (Executive Vice President) bought 3,195 shares of ZURA ($10,000) (dated 24 Apr 2024)

  36. 25 Apr 2024Insiders record

    Sidhu Someit (director) bought 1,186,901 shares of ZURA ($3.7M) (dated 24 Apr 2024)

  37. 25 Apr 2024Insiders record

    Howell Michael (See Remarks) bought 7,987 shares of ZURA ($24,999) (dated 24 Apr 2024)

  38. 25 Apr 2024Insiders record

    Munshi Amit (director) bought 159,744 shares of ZURA ($499,999) (dated 24 Apr 2024)

  39. 28 Mar 2024Filings record

    Director or officer change

  40. 23 Feb 2024Filings record

    Changed its auditor

Showing the newest 40 of 63 entries; narrow the window or the kind of data to see older ones.

Not listed: 69 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001855644
Ticker
ZURA
Domain
zurabio.com
Hq location
CA|LA JOLLA|92037 (1 unverified)
Name
EX-21.1, JATT Acquisition Corp, JATT Merger Sub 2, a Cayman Islands exempted company, Z33 Bio Inc., a Delaware corporation and 5 more
  • SEC Form 13F institutional holdings135 data points31 Mar 2023 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)100 records15 Jun 2021 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)250 data points9 Mar 2021 to 27 Oct 2026
  • SEC Form 4 insider transactions11 records, 32 data points5 Jun 2023 to 2 Mar 2026
  • FINRA short interest (twice monthly)261 data points31 Mar 2023 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1846 data points21 Mar 2023 to 20 Nov 2026